Catalyst Wire Dossier Catalyst Wire Dossier

Pirfenidone (Esbriet)

pirfenidone · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Pirfenidone (Esbriet), covering 2016-11-02 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]

See pricing